Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Eikon Therapeutics, Inc.

Eikon Therapeutics Announces Nature Methods Publication Highlighting its Pioneering Oblique Line Scan Technology
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Announces Appointment of Michael Klobuchar as Chief Operating Officer
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Management to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics to Provide Corporate Updates at the 42nd Annual J.P. Morgan Healthcare Conference
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Announces the Election of Robert L. Huffines to its Board of Directors
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Announces Business Update, Highlighting Pipeline and Clinical Development Progress
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Builds Leading Clinical Development Organization with Appointment of Senior Team with Extensive Industry Expertise
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Acquires Global Rights to Clinical-Stage Assets and Announces Emerging Drug Development Pipeline
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Announces $517.8 Million Series B Raise and Expansion of Executive Leadership Team
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Appoints Alfred Bowie Jr, PhD as Chief Financial Officer
From Eikon Therapeutics, Inc.
Via Business Wire
Eikon Therapeutics Closes $148 Million Series A Financing to Develop High-Throughput, Super-Resolution Microscopy for Drug Discovery
From Eikon Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.